Hongbo Pang

Hongbo Pang is an Associate Professor in the Department of Pharmaceutics at the University of Minnesota's College of Pharmacy. Their research focuses on cellular mechanisms of cancer and advanced drug delivery systems.

• Current NIH-funded projects (NIGMS, NCI, Biomedical Imaging)
• Active collaborations with Dehm, Antonarakis, and Drake in CRPC research

Research spans nanotechnology applications in medicine, including:

• Nanoparticle uptake mechanisms
• Bystander effect in drug delivery
• Peptide-guided therapeutic systems
• Obesity-related pharmacokinetics
• Glucocorticoid delivery optimization

Recent publications demonstrate expertise in:

• 2025: PEGylation for respiratory disease treatment
• 2024: Peptide targeting in autoimmune disorders
• 2023: Nanomaterials in tumor delivery
• 2022: Transportan peptide applications
• 2021: Macropinocytosis exploitation

Key methodologies include:

• Bystander-activated delivery systems
• Cell-penetrating peptide engineering
• Macropinocytosis pathway manipulation
• Tumor-targeted nanocarriers
• Therapeutic index optimization